The ChEMBL drug registry records tirzepatide at maximum phase 4 (approved), first approval 2022, parenteral, with a first-in-class GIP-agonist designation and a boxed-warning flag
Applying a concentrated copper peptide product into this environment is like sending construction workers to a job site that's already been prepped and cleared
Women of childbearing potential should employ reliable contraception during BPC-157 treatment if used clinically, pending establishment of safety in pregnancy
Pedrosa ML, Furtado MH, Ferreira MCF, Carneiro MM
Granular tissue is composed of newly formed connective tissue and minuscule blood vessels that appear on wound surfaces as part of the healing process
Compounds that raise BDNF tend to strengthen learning signals and support memory formation